Our collective results suggest that the suppression of metastasis of tumor cells through the inhibition of HDAC activity and the reversal of E-cadherin expression underlies the anticancer activity of a number of benzacetamide compounds, providing an important theoretical basis for the therapeutic effects of benzacetamide HDACi drugs. Here, CDH1 is linked to neoplasm.